AGIOS PHARMACEUTICALS, INC. Insider Trading for April 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for April 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 68,850 | |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.95 | 2,050 | 176,198 | 0 | 2.1 K to 0 (-100.00 %) |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 101,000 | |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 85.68 | 700 | 59,976 | 881 | 1.6 K to 881 (-44.28 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 84.78 | 1,300 | 110,214 | 1,581 | 2.9 K to 1.6 K (-45.12 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 25,154 | |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 77.17 | 500 | 38,585 | 57,196 | 57.7 K to 57.2 K (-0.87 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 76.17 | 800 | 60,936 | 57,696 | 58.5 K to 57.7 K (-1.37 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 75.04 | 400 | 30,016 | 58,496 | 58.9 K to 58.5 K (-0.68 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 73.90 | 1,300 | 96,070 | 58,896 | 60.2 K to 58.9 K (-2.16 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 78,567 | |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 79.49 | 2,113 | 167,962 | 0 | 2.1 K to 0 (-100.00 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 78.59 | 3,390 | 266,420 | 2,113 | 5.5 K to 2.1 K (-61.60 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 77.76 | 3,340 | 259,718 | 5,503 | 8.8 K to 5.5 K (-37.77 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 76.40 | 2,600 | 198,640 | 8,843 | 11.4 K to 8.8 K (-22.72 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 75.54 | 1,557 | 117,616 | 11,443 | 13 K to 11.4 K (-11.98 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |